SAN DIEGO–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ILMN&src=ctag” target=”_blank”gt;$ILMNlt;/agt; lt;a href=”https://twitter.com/hashtag/ILMN?src=hash” target=”_blank”gt;#ILMNlt;/agt;–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be
speaking at the following investor conference and invited investors to
participate via webcast.
Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA
June 12, 2019 at 10:00 am Pacific Time
The live webcast can be accessed in the Investor Relations section of
Illumina’s web site under the “company” tab at www.illumina.com.
A replay of the presentation will be posted on Illumina’s web site after
the event and will be available for at least 30 days following.
Illumina is improving human health by unlocking the power of the genome.
Our focus on innovation has established us as the global leader in DNA
sequencing and array-based technologies, serving customers in the
research, clinical and applied markets. Our products are used for
applications in the life sciences, oncology, reproductive health,
agriculture and other emerging segments. To learn more, visit www.illumina.com and
Jacquie Ross, CFA